ANGO — ANGIODYNAMICS INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1275187 ·
Last close
$15.49
Market Cap
$640.24M
52W High
$16.29
52W Low
$9.39
ADV30
382,763
Next earnings
2026-10-01
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| May 2026 | — | — | — | — | — | — | — |
| Feb 2026 | 78,423,000 | 41,479,000 | -6,429,000 | -8,084,000 | 260,678,000 | 37,810,000 | 87,321,000 |
| Nov 2025 | 79,433,000 | 44,783,000 | -2,490,000 | -6,350,000 | 269,681,000 | 41,638,000 | 93,348,000 |
| Aug 2025 | 75,711,000 | 41,857,000 | -7,898,000 | -10,903,000 | 265,642,000 | 38,762,000 | 86,787,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$3,089,000
Investing CF
$-5,949,000
Financing CF
$564,000
CapEx
$-2,581,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.87
As of
2026-07-19
Balance + Analyst (yfinance extras)
Retained Earnings
$-465,939,000
Inventory
$52,436,000
Receivables
$48,514,000
ST Investments
—
EBIT TTM
$-22,329,000
Pretax Income TTM
$-36,300,000
Interest Exp TTM
—
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$320,174,016
EBITDA
$188,000
Free Cash Flow
$21,770,250
Enterprise Value
$588,237,568
Total Cash
$53,864,000
Total Debt
$10,956,000
Shares Out
41,332,389
Trailing EPS
$-0.88
Book Value
$4.10
ROE
-20.8%
ROA
-5.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| May 2026 | 320,174,000 | -22,329,000 | -36,742,000 | 267,163,000 | 96,338,000 | 170,825,000 | 3,089,000 |
| May 2025 | 292,498,000 | -24,062,000 | -33,993,000 | 280,144,000 | 97,174,000 | 182,970,000 | -10,128,000 |
| May 2024 | 303,914,000 | -33,844,000 | -184,349,000 | 317,671,000 | 112,085,000 | 205,586,000 | -28,158,000 |
| May 2023 | 338,752,000 | -18,679,000 | -52,442,000 | 532,637,000 | 154,341,000 | 378,296,000 | 78,000 |
TTM Snapshot
Revenues TTM
$297,489,000
NetIncome TTM
$-210,369,000
OpCashFlow TTM
$0
Assets (Latest)
$280,144,000
Forward EPS
$-0.04
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $15.00 · spot: $15.52 · call volume: 28 · put volume: 131
Expected Move to 2026-10-16:
±$1.90
(12.24%) —
implied range
$13.62 –
$17.42
· ATM straddle on $15.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BRSYF | Brainsway Ltd. | $608.35M | $15.13 | — |
| MDXG | MIMEDX GROUP, INC. | $681.51M | $4.67 | — |
| SSII | SS Innovations International, Inc. | $591.14M | $2.95 | — |
| KIDS | ORTHOPEDIATRICS CORP | $588.78M | $22.55 | — |
| AVR | Anteris Technologies Global Corp. | $749.46M | $7.69 | — |
News headlines (Yahoo Finance, 1h cache)
AngioDynamics Sees MedTech Becoming Majority of Revenue in Fiscal 2027
2026-08-11 23:04 · Yahoo
AngioDynamics to Participate in Upcoming Investor Conferences
2026-07-28 12:30 · Yahoo
AngioDynamics (ANGO) Q4 2026 Earnings Call Transcript
2026-07-21 19:47 · Yahoo
AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands
2026-07-15 14:29 · Yahoo
AngioDynamics Inc (ANGO) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges
2026-07-14 19:00 · Yahoo
AngioDynamics (ANGO) Reports Q4 Loss, Beats Revenue Estimates
2026-07-14 11:15 · Yahoo
AngioDynamics Tops Revenue Forecasts and Raises Sales Outlook for Fiscal 2027 (ANGO)
2026-07-14 10:49 · Yahoo
AngioDynamics: Fiscal Q4 Earnings Snapshot
2026-07-14 10:18 · Yahoo
AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026
2026-06-30 12:00 · Yahoo
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
2026-06-23 17:06 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.